161 related articles for article (PubMed ID: 37750854)
21. Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China.
Chen R; Li S; Li Y; Zhu Q; Shi X; Xu L; Xu Y; Zhang W; Huang X; Wang J; Zha X
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3495-3501. PubMed ID: 34398298
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.
Song YX; Xu Z; Liang MX; Liu Z; Hou JC; Chen X; Xu D; Fei YJ; Tang JH
Cancer Med; 2022 Nov; 11(22):4085-4103. PubMed ID: 35502768
[TBL] [Abstract][Full Text] [Related]
23. A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer.
Shi W; Huang X; Wang Y; Wan X; He J; Xu Y; Zhang W; Chen R; Xu L; Zha X; Wang J
Front Endocrinol (Lausanne); 2022; 13():1042394. PubMed ID: 36506067
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: a study of 1247 patients.
Shao H; Sun Y; Na Z; Jing H; Li B; Wang Q; Zhang C; Cheng W
BMC Cancer; 2024 Jan; 24(1):112. PubMed ID: 38254060
[TBL] [Abstract][Full Text] [Related]
25. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
Sui L; Yan Y; Jiang T; Ou D; Chen C; Lai M; Ni C; Zhu X; Wang L; Yang C; Li W; Yao J; Xu D
Breast Cancer Res Treat; 2023 Nov; 202(1):45-55. PubMed ID: 37639063
[TBL] [Abstract][Full Text] [Related]
27. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Le-Petross HT; McCall LM; Hunt KK; Mittendorf EA; Ahrendt GM; Wilke LG; Ballman KV; Boughey JC
AJR Am J Roentgenol; 2018 Mar; 210(3):669-676. PubMed ID: 29381381
[TBL] [Abstract][Full Text] [Related]
28. Correlation between the contrast-enhanced ultrasound image features and axillary lymph node metastasis of primary breast cancer and its diagnostic value.
Xu H; Xu GL; Li XD; Su QH; Dong CZ
Clin Transl Oncol; 2021 Jan; 23(1):155-163. PubMed ID: 32488804
[TBL] [Abstract][Full Text] [Related]
29. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer.
Oruwari JU; Chung MA; Koelliker S; Steinhoff MM; Cady B
Am J Surg; 2002 Oct; 184(4):307-9. PubMed ID: 12383889
[TBL] [Abstract][Full Text] [Related]
30. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
[TBL] [Abstract][Full Text] [Related]
31. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.
Qiu SQ; Zeng HC; Zhang F; Chen C; Huang WH; Pleijhuis RG; Wu JD; van Dam GM; Zhang GJ
Sci Rep; 2016 Feb; 6():21196. PubMed ID: 26875677
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of combining clinicopathological, multimodal ultrasonic characteristics in axillary lymph nodal metastasis burden of patients with cT1-2N0 breast cancer.
Duan Y; Zhu Y; Nie F; Guan L; Jia Y; Chen K; Wang W
Clin Hemorheol Microcirc; 2022; 81(3):255-269. PubMed ID: 35342081
[TBL] [Abstract][Full Text] [Related]
34. Quantitative ultrasound image analysis of axillary lymph node status in breast cancer patients.
Drukker K; Giger M; Meinel LA; Starkey A; Janardanan J; Abe H
Int J Comput Assist Radiol Surg; 2013 Nov; 8(6):895-903. PubMed ID: 23526445
[TBL] [Abstract][Full Text] [Related]
35. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
36. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
[TBL] [Abstract][Full Text] [Related]
37. Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer.
Cha C; Ahn SG; Kim D; Lee J; Park S; Bae SJ; Kim JY; Park HS; Park S; Kim SI; Park BW; Jeong J
Int J Cancer; 2021 Oct; 149(8):1585-1592. PubMed ID: 34213778
[TBL] [Abstract][Full Text] [Related]
38. Lymph Node Predictive Model with in Vitro Ultrasound Features for Breast Cancer Lymph Node Metastasis.
Han P; Yang H; Liu M; Cheng L; Wang S; Tong F; Liu P; Zhou B; Cao Y; Liu H; Wang C; Peng Y; Shen D; Wang S
Ultrasound Med Biol; 2020 Jun; 46(6):1395-1402. PubMed ID: 32146007
[TBL] [Abstract][Full Text] [Related]
39. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
40. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
